Science is closing in on the issues surrounding estrogen use after menopause.
The Journal of the American Medical Association now reports a study of the effects of a combination of a particular type of an estrogen called "EE2" with a progestin called "NA".
Patients with osteoporosis who are on these medications had a significant improvement in bone density.
In addition, they did not have menstrual bleeding, which is present with other combinations of medicines.
But there are other considerations to discuss with your doctor before starting this therapy.
|This page is maintained by David M. Pilasky of the Office of Information Systems and was last updated November 11th, 1996.|